Ftse Mib
32.908,05
0,74%
DAX
18.068,21
0,26%
S&P 500
5.473,23
0,77%
NASDAQ
17.857,02
0,95%
Bitcoin
65.314,65
-1,76%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Australia ASX Aeon Metals Limited (AMLN) Aeon Metals Limited (AMLN) Notizie

AMLN

Aeon Metals (AMLN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:ASX:AMLN
DataOraFonteTitoloSimboloCompagnia
29/10/200913:34Dow Jones NewsUPDATE: Roche's New Diabetes Drug Works Better Than ByettaNASDAQ:AMLNAmylin Pharmaceuticals Inc.
29/10/200910:02Dow Jones NewsRoche: New Diabetes Drug Works Better Than Byetta - StudyNASDAQ:AMLNAmylin Pharmaceuticals Inc.
19/10/200923:21Dow Jones News2ND UPDATE:Galleon Holdings Include OSI Pharma,Huron ConsultingNASDAQ:AMLNAmylin Pharmaceuticals Inc.
19/10/200922:17Dow Jones NewsUPDATE: Galleon Holdings Include OSI Pharma, Huron ConsultingNASDAQ:AMLNAmylin Pharmaceuticals Inc.
19/10/200922:05Dow Jones NewsGalleon Holdings Include OSI Pharmaceuticals, Huron ConsultingNASDAQ:AMLNAmylin Pharmaceuticals Inc.
30/09/200912:16Dow Jones NewsNovo Nordisk's Diabetes Drug Victoza Successful In StudyNASDAQ:AMLNAmylin Pharmaceuticals Inc.
06/08/200914:28Dow Jones NewsNovo Nordisk CEO: Positive Victoza Reception In EuropeNASDAQ:AMLNAmylin Pharmaceuticals Inc.
21/07/200923:20Dow Jones NewsAmylin 2Q Loss Narrows On Cost-Cutting; Byetta Sales SlipNASDAQ:AMLNAmylin Pharmaceuticals Inc.
03/07/200913:01Dow Jones NewsUPDATE: Novo Nordisk Diabetes Drug Victoza Gets EU ApprovalNASDAQ:AMLNAmylin Pharmaceuticals Inc.
03/07/200912:06Dow Jones NewsNovo Nordisk's Victoza To Reach Market In A Few Weeks - CSONASDAQ:AMLNAmylin Pharmaceuticals Inc.
09/06/200912:30Dow Jones NewsDoctors Say New Diabetes Drugs Hold Great PromiseNASDAQ:AMLNAmylin Pharmaceuticals Inc.
09/06/200909:13Dow Jones NewsCORRECT: Study: Novo Nordisk's Diabetes Drug Beats Lilly's ByettaNASDAQ:AMLNAmylin Pharmaceuticals Inc.
09/06/200909:12Dow Jones NewsNovo Nordisk Diabetes Drug Liraglutide Successful In StudyNASDAQ:AMLNAmylin Pharmaceuticals Inc.
09/06/200909:12Dow Jones NewsStudy: Novo Nordisk's Diabetes Drug Beats Lilly's ByettaNASDAQ:AMLNAmylin Pharmaceuticals Inc.
07/06/200902:00Dow Jones NewsUPDATE: Weekly Diabetes Drug Byetta Outdoes CompetitorsNASDAQ:AMLNAmylin Pharmaceuticals Inc.
06/06/200921:22Dow Jones NewsStudy Shows Weekly Byetta Diabetes Drug Outdoes CompetitorsNASDAQ:AMLNAmylin Pharmaceuticals Inc.
02/06/200919:59Dow Jones NewsUPDATE: Amylin: 2 Dissidents To Replace Chairman, Lead DirNASDAQ:AMLNAmylin Pharmaceuticals Inc.
02/06/200919:36Dow Jones NewsAmylin: 2 Dissidents To Replace Chairman, Lead DirectorNASDAQ:AMLNAmylin Pharmaceuticals Inc.
27/05/200922:37Dow Jones NewsUPDATE: Amylin: Dissidents Likely Got Up To Two Board SeatsNASDAQ:AMLNAmylin Pharmaceuticals Inc.
27/05/200922:05Dow Jones NewsEastbourne Claims Success In Electing Directors To Amylin BoardNASDAQ:AMLNAmylin Pharmaceuticals Inc.
21/05/200921:02Dow Jones NewsHedge Fund Mgr Schoenfeld Backs Icahn/Eastbourne Amylin SlateNASDAQ:AMLNAmylin Pharmaceuticals Inc.
18/05/200914:17Dow Jones NewsMore Proxy Advisers Back Dissidents' Amylin Board NomineesNASDAQ:AMLNAmylin Pharmaceuticals Inc.
16/05/200900:24Dow Jones NewsUPDATE: Risk Metrics Backs Three Dissident Amylin DirectorsNASDAQ:AMLNAmylin Pharmaceuticals Inc.
15/05/200923:53Dow Jones NewsRisk Metrics Backs Three Dissident Directors For Amylin BoardNASDAQ:AMLNAmylin Pharmaceuticals Inc.
14/05/200917:13Dow Jones NewsUPDATE: Icahn Fires Back At Amylin Over Latest LetterNASDAQ:AMLNAmylin Pharmaceuticals Inc.
04/05/200923:29Dow Jones NewsAmylin To Trim Sales Team by 35%, Sees $45 Million Savings In '10NASDAQ:AMLNAmylin Pharmaceuticals Inc.
30/04/200920:55Dow Jones NewsDEALWATCH: Lilly Can't Afford To Double Down With AmylinNASDAQ:AMLNAmylin Pharmaceuticals Inc.
28/04/200922:03Dow Jones NewsAmylin Proxy Battle Adds To Debate Over What Makes A 'Group'NASDAQ:AMLNAmylin Pharmaceuticals Inc.
24/04/200911:47Dow Jones NewsUPDATE: Novo Nordisk Has Big Hopes For EU Victoza LaunchNASDAQ:AMLNAmylin Pharmaceuticals Inc.
20/04/200921:01Dow Jones NewsUPDATE: US Drug Stocks Flee Into Negative TerritoryNASDAQ:AMLNAmylin Pharmaceuticals Inc.
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:ASX:AMLN

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
STMMI
ST Microelectronics
BIT
TEN
Tenaris
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
BAMI
Banco BPM
BIT
SRG
Snam
BIT
NEXI
Nexi S.p.A
BIT
SPM
Saipem
BIT
TRN
Terna Trasmissione Elett...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network